je.st

Home › etfs

Tag: etfs

Liquidity risks overhang high-yield ETFs

2015-08-01 11:19:47| IT Services - Topix.net

NEW YORK: Shareholders in the AdvisorShares Peritus High Yield ETF who sold in late 2014 are probably not the last to pay up for liquidity risk, a growing hazard for some fixed-income investors bracing for the first Federal Reserve interest rate hike in nearly a decade. ETFs created in recent years and dealing in often illiquid or thinly traded junk bonds, emerging-markets debt and bank loans are an untested market force that may increase selling pressures in a market turndown, analysts say.

Tags: risks liquidity etfs overhang

Best And Worst Q3'15: Industrials ETFs, Mutual Funds And Key Holdings

2015-07-30 18:52:12| Air Courier - Topix.net

The Industrials sector ranks third out of the 10 sectors as detailed in our Q3'15 Sector Ratings for ETFs and Mutual Funds report. It gets our Neutral rating, which is based on aggregation of ratings of 19 ETFs and 17 mutual funds in the Industrials sector.

Tags: key funds worst mutual

Best And Worst Q3'15: Consumer Staples ETFs, Mutual Funds And Key Holdings

2015-07-23 19:56:16| Agriculture - Topix.net

The Consumer Staples sector ranks first out of the 10 sectors as detailed in our Q3'15 Sector Ratings for ETFs and Mutual Funds report. It gets our Attractive rating, which is based on aggregation of ratings of 10 ETFs and 14 mutual funds in the Consumer Staples sector.

Tags: key consumer funds worst

Biotech ETFs: 3 Questions For IShares Investing Expert

2015-07-23 06:55:09| Biotech - Topix.net

TF investors in biotechnology stocks may be rattled by the nose-dive of the first heavyweight out of the earnings gate. , the $10 billion biotech exchange traded fund, has lost 0.8% in the past three trading sessions as 's reports this week, IBD spoke to Tushar Yadava, an iShares investment strategist, on whether the biotech sector has room to run: Tushar Yadava: Biotech investors entering for the first time are likely doing so in search of consistent growth - something the sector has delivered for a few years running.

Tags: questions expert investing biotech